Akebia Therapeutics, Inc.AKBANASDAQ
LOADING
|||
Switch Symbol:
Operating Income Performance
Above historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-50.47M
↑ 68% above average
Average (9y)
$-156.22M
Historical baseline
Range
High:$-46.26M
Low:$-377.83M
CAGR
-2.2%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-50.47M | -9.1% |
| 2023 | $-46.26M | +42.7% |
| 2022 | $-80.78M | +69.5% |
| 2021 | $-264.50M | +30.0% |
| 2020 | $-377.83M | -32.0% |
| 2019 | $-286.29M | -60.7% |
| 2018 | $-178.14M | -122.9% |
| 2017 | $-79.92M | +41.4% |
| 2016 | $-136.46M | -121.8% |
| 2015 | $-61.51M | - |